Angela Gillespie, former VP of marketing for NeuWave Medical, has returned to W20 Group as chief strategy officer of its global MedTech practice, a new post overseeing its medical device business across the firm's agencies.
Gillespie started San Francisco-based W20's medical device practice in 2007. She will be based in Minneapolis with a mandate to double the firm's partnerships with medtech companies over the next five years.
W20 chief client officer Jennifer Gottlieb said factors like personalized medicine, digital health and medical device and diagnostics have the medtech sector poised for rapid growth over the next decade. She said Gillespie knows the sector "cold" and will "galvanize" the firm's offering.
Prior to Neuwave, which was acquired by Johnson & Johnson in April, Gillespie was senior market development leader for Covidien's peripheral and venous vascular business units, since acquired by Medtronic.
On the agency side, she earlier advised medical device clients at MDMC and was a VP at FischerHealth and account manager at Porter Novelli.
The future of DTC should foster understanding and trust, as well as improving clinical conversations.
Healing the Sick Care System: Why People Matter, a new book from FINN Partners chair global health and purpose Gil Bashe, says that the current healthcare system is not broken because it lacks innovation, talent or investment, but because it has lost sight of the people it exists to serve.
Jeff Smokler, former president at healthcare specialist imre, joins Washington-based Avoq to head its PA practice.
